Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
03/17/2005 | US20050059729 Substituted cyclic compounds |
03/17/2005 | US20050059723 Indole or carbazole oximes such as 1-(4-Hydroxyphenyl)-2-methyl-1H-indole-3-carbaldehyde oxime; estrogen receptor modulators for treating bone disorders, nervous system disorders, proliferative disorders including cancer, skin disorders, urogenital disorders and cardiovascular disorders |
03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
03/17/2005 | US20050059675 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia |
03/17/2005 | US20050059651 Lactam derivatives as antagonists for human 11cby receptors |
03/17/2005 | US20050059648 Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof |
03/17/2005 | US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity |
03/17/2005 | US20050059609 New alpha crystalline form of perindopril tert-butylamine salt |
03/17/2005 | US20050058920 Organophotoreceptor with charge transport compound with an azine group |
03/17/2005 | US20050058917 Charge transport compound containing at least two carbazolecarboxaldehyde substituted- hydrazone groups |
03/17/2005 | DE10337839A1 Indolin-Derivate Indoline derivatives |
03/17/2005 | CA2572750A1 Heterobicyclic compounds as pharmaceutically active agents |
03/17/2005 | CA2537752A1 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
03/17/2005 | CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
03/16/2005 | EP1514869A1 Indole, indazole, and benzazole derivative |
03/16/2005 | EP1513812A1 Substituted indoles |
03/16/2005 | EP1513811A1 Non-peptidic brs-3 agonists |
03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
03/16/2005 | EP1513809A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
03/16/2005 | EP1355903B1 Pyrazole derivatives against tgf overexpression |
03/16/2005 | EP1322160B1 Active ingredient combinations comprising insecticidal and acaricidal properties |
03/16/2005 | EP1112254A4 Cyanine dyes and synthesis methods thereof |
03/16/2005 | EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
03/16/2005 | EP0874625B1 Indane derivatives for antipsychotic compositions |
03/16/2005 | EP0812308B1 Method for synthesis of aryl difluoromethyl ethers and the like |
03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
03/16/2005 | CN1596247A Lactam derivatives as antagonists for human 11CBY receptors |
03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
03/16/2005 | CN1193084C Electro Chromotropic solution containing hydrazone compound |
03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
03/16/2005 | CN1193024C Process for producing optically active sulfoxide devivative' |
03/16/2005 | CN1193018C New heterocyclic derivative and its medical use |
03/16/2005 | CA2480218A1 New derivatives of benzoindoline, preparation thereof, and pharmaceutical compounds containing them |
03/15/2005 | US6867320 Prostaglandin inhibitor; suppression leukotriene; antiinflammatory agents; rheumatic diseases |
03/15/2005 | US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs |
03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
03/15/2005 | US6867222 Nociceptin analogs |
03/15/2005 | US6867209 Indole-type derivatives as inhibitors of p38 kinase |
03/15/2005 | US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm |
03/15/2005 | US6867200 Anticancer agents; anticoagulants |
03/15/2005 | US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
03/15/2005 | CA2260711C Antibacterial compounds for ralstonia solanacearum |
03/15/2005 | CA2221946C Production process of cyclic compound |
03/15/2005 | CA2086914C Quinolone-and naphthyridone-carboxylic acid derivatives |
03/15/2005 | CA2063671C Aminoguanidines |
03/10/2005 | WO2005021504A2 New crystalline forms of carvedilol |
03/10/2005 | WO2005021503A1 Aminopropanol derivatives |
03/10/2005 | WO2005021502A1 METHOD FOR PRODUCING OPTICALLY ACTIVE THREO-β-ALKYLTRYPTOPHAN DERIVATIVE AND INTERMEDIATE THEREOF |
03/10/2005 | WO2005021501A1 Minimally invasive physiological function monitoring agents |
03/10/2005 | WO2005021486A1 Ester derivative and medicinal use thereof |
03/10/2005 | WO2005021465A1 Method for producing aromatic unsaturated compound |
03/10/2005 | WO2005020985A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
03/10/2005 | WO2003007875A9 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
03/10/2005 | US20050054857 Synthesis of pyrroles |
03/10/2005 | US20050054713 3-Substituted oxindole beta3 agonists |
03/10/2005 | US20050054712 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators |
03/10/2005 | US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas |
03/10/2005 | US20050054710 Inhibits effect on various receptor tyrosine kinases and CDK (cyclin dependent kinases) complexes and on the proliferation of endothelial cells and various tumor cells |
03/10/2005 | US20050054709 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders |
03/10/2005 | US20050054696 Indole compounds and medicinal use thereof |
03/10/2005 | US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes |
03/10/2005 | US20050054680 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
03/10/2005 | US20050054671 Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation |
03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
03/10/2005 | US20050054637 Prophylaxis, therapy cardiovascular disorders |
03/10/2005 | US20050054635 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders |
03/10/2005 | US20050054631 Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP) |
03/10/2005 | US20050054582 Para-amino benzoic acids as integrin antagonists |
03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
03/09/2005 | EP1512397A1 O-substituted hydroxyaryl derivatives |
03/09/2005 | EP1511770A2 Immunoadhesin comprising a glycoprotein vi domain |
03/09/2005 | EP1511729A1 Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds |
03/09/2005 | EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
03/09/2005 | EP1511727A2 Aromatic sulfones and their medical use |
03/09/2005 | EP1511726A1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol |
03/09/2005 | EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
03/09/2005 | EP1511704A1 Polymerisation inhibitor |
03/09/2005 | EP1511480A2 Inhibitors of glycoprotein vi |
03/09/2005 | EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
03/09/2005 | EP1511385A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems |
03/09/2005 | EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
03/09/2005 | EP1057814B1 Tetrahydrobenzindole derivatives |
03/09/2005 | CN1592738A Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition |
03/09/2005 | CN1592623A Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity |
03/09/2005 | CN1590465A Cyanine compound, optical recording material, and optical recording medium |
03/09/2005 | CN1590372A Arylphenyl-substituted cyclic ketoenols |
03/09/2005 | CN1589906A New oral formulation for 5-HT4 agonists or antagonists |
03/09/2005 | CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
03/09/2005 | CN1192015C Cell adhesion inhibitors |
03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
03/08/2005 | US6864260 Inhibit p38- alpha kinase using compounds of the formula and the pharmaceutically acceptable salts thereof, or a pharmaceutical composition thereof, wherein noninterfering substituent; |
03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
03/03/2005 | WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors |
03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
03/03/2005 | WO2005019173A1 Process for pure perindopril tert-butylamine salt |
03/03/2005 | WO2005019172A1 Indol-2-amides as glycogen phosphorylase inhibitors |